Innovation is often seen as a universal concept. But if you explore how different industries innovate, you’ll find a richer and more complex picture. I’ve worked on innovation briefs across many different categories over the years, but the way we’ve approached ‘new product development’ has been very different.
Pharmaceutical companies, fashion brands, tech startups, and breakfast cereal makers all innovate. Yet their timescales, risks, regulations, and success criteria vary greatly.
Recognising these differences changes how we view the approach and requirements of innovation.
Let’s delve into four distinct categories.
Pharma: The Long Game
Patience is a strategic asset in the pharmaceutical industry. Drug development is one of the most costly and time-consuming processes in any sector. Developing a new drug can take 10 to 15 years and cost around $2 billion.
The failure rate is staggering. Most drug candidates that enter clinical trials never reach the market.
Still, the industry keeps investing. Why? Because the potential rewards are massive. Without innovation, a pharmaceutical company has a ticking clock. Patents expire, and generics fill the market.
Pharma's innovation is defined by rigour and portfolio thinking.
Rigour is essential due to strict regulatory and ethical standards around drug safety. Portfolio thinking means no single drug can support an entire organisation’s innovation strategy. Companies spread risk across various compounds, knowing that most will fail, but a single success can cover everything.
Pharma doesn’t move as fast as tech startups. It builds long-term processes with staged investments and careful gatekeeping. There's a tolerance for years of work that may ultimately fail.
Fashion: Innovation at the Speed of Culture
In fashion, almost everything shifts. While pharma measures innovation in decades, fashion counts in weeks. Fast fashion, led by brands like Zara and H&M, has turned a two-season cycle into a continuous flow of new products. Zara, for example, can take a design from concept to store in just two weeks.
This type of innovation is about cultural awareness and operational agility. Zara’s model focuses on how it produces rather than what it produces. Integrated supply chains, small production runs, and feedback loops allow for real-time responses to customer preferences.
Fashion also highlights where innovation happens. In pharma, it’s in the lab. In fashion, it’s where design, supply chain, and trend forecasting intersect. This blend of creativity and precision is hard to replicate.
However, fashion faces a growing tension between rapid innovation and sustainability. The environmental impact of producing vast amounts of short-lived clothing is significant. This poses a challenge: how to maintain momentum while managing scarce resources.
The companies that solve this will shape the industry's future.
Technology: Iteration as Philosophy
The tech sector has greatly influenced modern views on innovation, sometimes negatively. Familiar mantras like “move fast and break things” can encourage poor quality if misapplied.
Top tech companies treat product development as a continuous loop, not a linear path. The model of research, development, and launch has been replaced by a more fluid approach. Products are released early, user behaviour is observed, and the product evolves based on feedback.
The launch is just the start of the innovation journey.
This method works in tech partly because software updates are cheap and instant. The cost of making mistakes is low. This allows for quick corrections without losing years of effort or money.
What tech has encouraged is the practice of testing assumptions early. Instead of creating a complete product, you build a minimal version to learn if your core idea is correct.
This principle has spread beyond tech for good reason. The logic is sound: reduce the cost of being wrong by failing sooner.
FMCG: The Innovation Paradox
Fast-moving consumer goods (FMCG) present a unique innovation challenge. These markets are large, competitive and have tiny margins. Consumers tend to stick to familiar brands, making it hard to disrupt habits.
This creates the FMCG innovation paradox. Companies like Unilever, Procter & Gamble, and Nestlé invest heavily in innovation. But their size makes radical changes risky and rare.
New flavours, reformulated products, and improved packaging are the staples of FMCG innovation. These are incremental, carefully tested, and rolled out with military precision.
The testing process in FMCG is thorough. New products often go through consumer research, regional trials, and retail performance modelling. The innovation funnel is highly systemised. A product is deemed a failure if it doesn’t achieve a sufficient repeat purchase rate.
Yet disruption does happen, often from entrepreneurs and challenger brands.
The craft beer movement challenged major breweries. Direct-to-consumer brands disrupted legacy personal care giants. Often, disruption arises from a different model of engaging with consumers.
IN SUMMARY
When you compare these four sectors, the differences are clear.
This means there is no single template for effective innovation. The best approach depends on your industry. Consider your failure costs, market pace, regulations, and consumer expectations.
Recognising these differences and adapting your innovation process is essential for any organisation. The challenge lies not in finding a universal formula but in understanding your industry's rhythm and ensuring your approach is fit for purpose.
